Tag: Philips
Philips to lay off warehouse workers
April 8, 2025HME News Staff
PITTSBURGH – Philips Respironics will lay off 14 workers at a facility in Westmoreland County starting May 23, according to a Worker Adjustment and Retraining Notification Act (WARN) notice filed by the company. The positions being eliminated include warehouse operators, managers and coordinators, and an analyst. “We’re implementing this action in line with all local requirements and are supporting the impacted employees,” said Mario Fante, global external relations director,...
Encore integrates Nexus with cloud-based platforms
March 12, 2025HME News Staff
LIVINGSTON, Tenn. – Encore Healthcare has integrated its Nexus program with React Health, Mōvair and Philips cloud-based ventilator management platforms. These integrations mark the first of several integrations that will significantly reduce the workload for HME providers managing ventilator patients, allowing for streamlined compliance management, the company says. “Our mission at Encore Healthcare is to continuously innovate and drive better outcomes for patients with chronic respiratory...
Philips says ‘momentum’ continues for sleep business
February 28, 2025Liz Beaulieu, Editor
AMSTERDAM – With its recent clearance in France, the Sleep & Respiratory Care business at Philips can once again sell products in all countries except for the United States.
“If you talk about S&RC, indeed, the momentum is coming into that business again,” said Roy Jakobs, CEO, during a Feb. 19 conference call to discuss the company’s fourth quarter and full year financial results for 2024. “(It’s) driven by the return to the market outside of the U.S.,...
In brief: Philips improves orders, VGM & Synapse name new execs, GAMES joins ACMESA
February 21, 2025HME News Staff
AMSTERDAM – Philips reported sales of EUR 18 billion in 2024, comparable sales growth of 1% and EUR 5 billion in the fourth quarter, also comparable sales growth of 1%, despite a double-digit decline in China.
The company reported comparable order intake increased 1% in 2024 and 2% in the fourth quarter, and income from operations was EUR 529 million in 2024 and EUR 199 million in the fourth quarter.
“Despite double-digit declines in demand in both consumer and health...
Philips updates vent instructions
November 25, 2024HME News Staff
WASHINGTON – Philips has updated its instructions for using Trilogy Evo, EvoO2, EV300, Evo Universal, Aeris EVO, Garbin EVO and LifeVent EVO2 due to risk of inaccurate flow measurements caused by certain in-line nebulizer placements, according to the U.S. Food and Drug Administration. The company says to be aware that this issue may affect any device that has ever been used with in-line nebulizer treatments. The updated instructions include making sure all alarms are set appropriately and keeping...
Philips reports improvement in profitability
October 28, 2024HME News Staff
AMSTERDAM – Philips reported group sales of EUR 4.4 billion, with flat comparable growth, and adjusted EBITDA margin of 11.8%, up 160 basis points, for the third quarter of 2024.
In the Connected Care business, the company reported comparable sales were flat, with growth in Enterprise Informatics and Sleep & Respiratory Care offset by a low-, single-digit decline in Monitoring, on the back of high-teens growth in the same period last year.
“Strong improvement in profitability...
Philips issues correction for vents
October 8, 2024HME News Staff
CAMBRIDGE, Mass. – Philips Respironics has issued a voluntary correction for Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal and Trilogy EV300 ventilators regarding the use of in-line nebulizers.
The company has determined that, in some circumstances, the use of in-line nebulizers placed in certain locations may lead to aerosol deposits forming over time on the ventilator flow sensor. Should this occur, there is a possibility of patient impact due to one or more of the following...
PSN Labs responds to Philips lawsuit
October 7, 2024HME News Staff
PITTSBURGH – PSN Labs has disputed claims made by Philips that the lab caused “significant damage” to the company by conducting “numerous egregious errors in its testing and analysis” related to recalled sleep and respiratory devices. In a response filed Sept. 27 in the U.S. District Court for the Western District of Pennsylvania, PSN says the company “has continued to mischaracterize testing results in an effort to conceal the ultimate foam degradation issue.”...
In brief: Industry’s warning, Philips’ lawsuit, AdaptHealth’s results, NSM’s potential sale
August 6, 2024HME News Staff
ARLINGTON, Va. – The now expired 75/25 blended Medicare reimbursement rates served as a lifeline for many HME companies in non-bid, non-rural areas and immediate intervention is needed to preserve this infrastructure that allows individuals to manage their medical needs at home, according to a new report from AAHomecare.
The report is based on a recent survey that found an overwhelming 93.5% of respondents have had to make difficult operational changes in response to the expired rates...
Philips blames lab for breadth of recall
August 5, 2024HME News Staff
PITTSBURGH – Philips says PSN Labs conducted “numerous egregious errors in its testing and analysis” related to the company’s recalled sleep and respiratory devices, causing it “significant damage.”
In a lawsuit filed July 29 in U.S. District Court for the Western District of Pennsylvania, Philips says PSN’s work was a big reason it initiated a worldwide recall of more than 15 million sleep and respiratory devices in June 2021 and that the company...